(3-mercaptopropyl)trimethoxysilane has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abnous, K; Ansari, L; Hanafi-Bojd, MY; Malaekeh-Nikouei, B; Moosavian Kalat, SA; Taghdisi, SM | 1 |
1 other study(ies) available for (3-mercaptopropyl)trimethoxysilane and Breast Neoplasms
| Article | Year |
|---|---|
MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Epirubicin; Humans; MCF-7 Cells; Nanoparticles; Organosilicon Compounds; Particle Size; Silanes; Silicon Dioxide | 2018 |